Introduction
In pregnancies complicated by diabetes, maternal and subsequent fetal hyperglycemia will lead to an increased fetal secretion of insulin. The degree of fetal hyperinsulinemia is reflected in the amniotic fluid concentration of C-peptide, the connecting peptide of proinsulin, which probably reaches the amniotic fluid via the fetal urine. Several investigators have shown an association between elevated levels of C-peptide in the amniotic fluid and neonatal complications in diabetic pregnancies [15, 20] . Neonatal disorders such as respiratory disturbances, hypoglycemia, hyperbilirubinemia and feeding difficulties may reflect delayed functional maturation of different organs. So far, only the functional maturity of the lung can be assessed prenatally, by determination of the lecithin/ sphingomyelin (L/S)-ratio, or lately by estimation of other surfactant components in the amniotic fluid [7] . Among these surf ace-active phospholipids, phosphatidyl glycerol is considered to be a reliable indicator of pulmonary maturity not only in normal but also in diabetic pregnancies [2, 8] . · The aim of the present study was to assess the possibility of a relationship between the level of C-peptide and the presence of phosphatidyl glycerol in the amniotic fluid, in strictly controlled diabetic pregnancies. 
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Materials and methods
Subjects
The study comprised a consecutive series of 36* pregnant diabetic patients, classified as suggested by WHITE [23] . Gestational diabetes was diagnosed by a 3 hour, 50 gram oral glucose tolerance test as described earlier [6, 9] . Twenty-one of the patients were insulin-treated gestational diabetic women (White class AB) and 15 were insulindependent diabetic women (12 of classes B-D and 3 of class F). All patients were subjected to a program of strict metabolic control during their pregnancy [16] . Blood glucose levels were monitored at home by the patients either by means of reagent strips alone or by a reflecto-meter. The insulin dose was adjusted according to the blood glucose values with the goal being to keep the blood glucose within the physiological range, i.e. between 3.0 and 6.5mmol/l.
Amniotic fluid investigations
Transabdominal amniocentesis was performed at 36-37 weeks of gestation as part of the routine program for fetal surveillance in diabetic women. The presence or absence of phosphatidyl glycerol was assessed on centrifuged (1100 χ g; 5 minutes) amniotic fluid samples, kept frozen and stored at -20 °C until analysis. Phosphatidyl glycerol was determined as described by HALLMAN and TERAMO [8] , by two-dimensional thin-layer chromatography. The phospholipids were stained by iodine vapors and the presence of phosphatidyl glycerol was recorded as an indicator of pulmonary maturity [8] . The lower detection limit for phosphatidyl glycerol in amniotic fluid was 0.33 Mg/ml. C-peptide in the amniotic fluid was measured by radioimmunoassay [10] after treating the samples with polyethylene glycol to remove insulinbinding, antibodies [11] . FlSHER's exact probability test and the MANN-WHITNEY U test were used for statistical analyses; p < 0.05 was considered as statistically significant. birth wei^it of the infants (r = 0.50: significantly hinter than that for uon<Uahetic p<OOl) (Fig. 1) . The C-peptide concentrations pregaancies(OJ8±0.02nniol/l) [17] . cud not differ, on the average, between patients The C-peptide level in ainuiotie fluid in the present m whom phoshatidyl giycerol was present in study did not discriminate between the presence the amnioGc fluid (n = 15: 0.56 ± 0.06 nrnol/1) or absence of phosphatidyl glyceroL This observaand those in whom it was absent (n = 21 ; tion is in accordance with previous findings in dia-0.43 ± 0.05 nrno!/l). The gestational age at amnio-betic pregnancies in that there was uo correlation ceotesis did not differ between these two groups, between the C-peptide level and the L/S ratio in Two cases of minor respiratory disorders (transient the amniotic fluid [21 ] , nor between the C-peptide tacfaypnea, pneuinothorax) occurred in infants of level in cord blood and the occurrence of RDS in the group in which phosphatidyl glycerol was the newborn infant [19] . present. These infants were delivered by Cesarean The hypothesis that hyperinsulineinia per $e is the section from women with gestational diabetes at major factor underlying the disturbed surfactant term after an uncomplicated prenatal course.
production in diabetic pregnancy can be dial· No attempt was made to correlate phosphatidyl lengpd. According to this hypothesis, one mediaglycerol to the neonatal outcome, because of the nism by which insulin exerts its inhibitory influtime lag, of more than 2 weeks between amnio-ence on lung maturation could be by decreasing centesis and delivery in White classes AB and the availability of substrates for surfactant syn-B-D.
thesis. Thus, the breakdown of lung glycogen. which is the major carbohydrate source for surfactant synthesis, could be inhibited by excess insulin. The marked changes in the concentration A T\* * 4 Discussion O f i nsu ij n receptors that occur during development The main observation in this study was that the of Λβ fetal rat lun g [18] suggest the importance of biochemical maturation of the fetal lung was not another variable that could significan y modulate disturbed to any appreciable degree by maternal glycogen metabolism in the lung. It can be specudiabetes. Phosphatidyl glycerol was present in lated that a delayed disappearance of insulin 40 per cent of the diabetic pregnancies which is a receptors and an increased receptor affinity for figure that corresponds to our findings in non-insulin in the fetal lung in the offspring of diabetic diabetic pregnancies at a comparable gestational women could lead to enhanced insulin sensitivity age (36 weeks) [22] and is also similar to reports and hence, a decrease in glycogenolysis and in of other investigators [1, 3] . surfactant production. Interestingly, monocytes This apparently normal degree of fetal lung from infants of mothers with gestational diabetes maturation is probably attributable to the strict have more insulin receptors than normal, and these control of the diabetic state during the preg-receptors also show an increased affinity for nancies. Indeed, in these women the achieved insulin [14] . Another possibility that is supported metabolic control of maternal blood glucose levels by experimental data [4, 5] is that hyperglycemia approached normal values, however, there was per se could lead to impaired glycogen degradation evidence of some degree of fetal hyperinsulinemia, and decreased surfactant production. as assessed by the concentration of C-peptide in In conclusion the present study shows that with the amniotic fluid. Although the mean value for rigorous metabolic control of the pregnant diathis concentration was close to that found previ-betic patient, the presence or absence of phosously for diabetic pregnancies with an uneventful phatidyl glycerol shows no apparent relationship neonatal outcome (0.51 ± 0.9 rimol/1), it was to the level of C-peptide in amniotic fluid.
Summary
The concentrations of C-peptide and phosphatidyl glycerol diabetic women. Twenty-one patients who were being in the amniotic fluid were determined in 36 pregnant treated with insulin for gestational diabetes as well as 15 patients who were insulin dependent were studied. All patients were subjected to a program of strict metabolic control, and amniocentesis was performed at gestational week 36-37. Phosphatidyl glycerol was present in the amniotic fluid in 15 cases and absent in 21. The mean concentration of C-peptide did not differ whether phosphatidyl glycerol was present or absent. (C-peptide: 0.56 ± 0.06 and 0.43 ± 0.05 nmol/1 respectively). Although the mean value for amniotic fluid C-peptide in both groups was close to that in diabetic pregnancies with an uneventful neonatal outcome, it was significantly higher than that in non-diabetic pregnancies, indicating minor fetal hyperinsulinemia. The level of C-peptide in the amniotic fluid showed a correlation to the subsequent birthweight of the infant (r = 0.50; p < 0.01). It is concluded that with rigorous metabolic control of the pregnant diabetic patient, the presence or absence of phosphatidyl glycerol, as an index of fetal lung maturity, is apparently not related to the level of C-peptide in the amniotic fluid.
Key words: Amniotic fluid, C-peptide, diabetes in pregnancy, phosphatidyl glycerols, prenatal diagnosis. 21 . La concentration moyenne de peptide-C n'etait pas differente qu'il y ait ou non du phosphatidyl glycerol (respectivement, peptide-C = 0,56 ± 0,06 et 0,43 ± 0,05 nmol/1). Bien que la valeur moyenne de peptide-C dans le liquide amniotique ne fit appel dans les 2 groupes qu'aux grossesses diabetiques avec un devenir neonatal sans probleme, cette valeur n'etait significativement plus elevee que dans les grossesses chez les non-diabetiques, ce qui indique une hyperinsulinemie foetale minime. Le taux de peptide-C dans le liquide amniotique a montre une correlation avec le poids de naissance ulterieur de l'enfant (r = 0,50;p < 0,01). Les auteurs concluent qu'avec un contröle metabolique rigoureux chez les diabetiques enceintes, la presence ou l'absence de phosphatidyl glycerol, en tant qu'index de la maturite pulmonaire foetale, n'est apparemment pas en correlation avec le taux de peptide-C du liquide amniotique.
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